Posted December 27, 2019
Emerging research underscores the critical need to protect compounded bioidentical hormones. Action Alert! Almost six million Americans suffer from Alzheimer’s disease, and it is projected to afflict many more in coming years. Big Pharma has been unable to produce drugs that treat this debilitating disease. New research, however, is suggesting that Alzheimer’s is more complex than previously thought, requiring an individualized approach that can include hormone replacement therapy. Unfortunately, the FDA is poised to eliminate consumer access to compounded, bioidentical hormones. Read more.